Humane Genomics is developing a platform to engineer cancer killing viruses with unprecedented specificity and efficiency. Our first indication is liver cancer. We are based in New York City and backed by amazing investors. (YC S21)
| Website | http://humanegenomics.com |
| Employees | 9 (6 on RocketReach) |
| Founded | 2019 |
| Address | 180 Varick Street Floor 6, New York, New York 10014, US |
| Technologies |
JavaScript
,
HTML
,
PHP
+13 more
(view full list)
|
| Industry | Biotechnology Research, Outcome Management (Healthcare), Social/Platform Software |
| Keywords | Cancer Therapy, Oncolytic Virus, Viral Therapy, Precision Oncology, Targeted Therapy, Gene Therapy, Immuno-Oncology, Personalized Medicine, Genetic Engineering, Liver Cancer Treatment, Biological Therapeutics, Cancer Research, Cancer Treatment, Oncology, Biotechnology, Drug Development, Pharmaceutical, Cancer Diagnostics, Clinical Trials |
| Competitors | Thermo Fisher Scientific, Boehringer Ingelheim, Illumina, Myriad Genetics, GeneDx, NantHealth, The Translational Genomics Research Institute, Admera Health, 2bPrecise, Biomodels, LLC +50 more (view full list) |
Looking for a particular Humane Genomics employee's phone or email?
Peter Weijmarshausen is the CEO and Co-founder of Humane Genomics.
6 people are employed at Humane Genomics.
Humane Genomics is based in New York, New York.